Researchers from MIT, Brigham & Women’s Hospital and Draper have developed a Bluetooth-controlled ingestible capsule that can sense the temperature of its environment and reside in the stomach for at least a month.
The device, which was tested in an animal study and composed of 3D-printed parts, is powered by a small silver oxide battery and relays data to a smartphone in close range.
The researchers predicted that its sensor could one day communicate with an array of wearable technologies. Their study was published in a December issue of the journal Advanced Materials Technologies.
“Our system could provide closed-loop monitoring and treatment, whereby a signal can help guide the delivery of a drug or tuning the dose of a drug,” Giovanni Traverso, a scientist in MIT’s Department of Mechanical Engineering, told MIT News.
“We are excited about this demonstration of 3-D printing and of how ingestible technologies can help people through novel devices that facilitate mobile health applications,” Robert Langer, MIT’s David H. Koch Institute professor, added.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.